Dr. Leslie A. Cotto, MD

Dr. Cotto practices at Palm Beach Diabetes and Endocrine Specialists PA in West Palm Beach, Florida.

Dr. Cotto's NPI, 1609167659, was assigned on April 26, 2011. Dr. Cotto graduated from San Juan Bautista School of Medicine in 2009. Dr. Cotto holds Florida license ME119732.

Dr. Cotto's primary practice is Palm Beach Diabetes and Endocrine Specialists PA, at 1515 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 659-6336.

Dr. Cotto's primary practice is Palm Beach Diabetes and Endocrine Specialists PA in West Palm Beach, Florida. The medical group on file is Palm Beach Diabetes & Endocrine Specialists, PA. Dmand AI also links Dr. Cotto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cotto practices. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Cotto's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Cotto is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dr. Cotto is licensed in Florida.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, hypercalcemia, obesity, osteoporosis and overactive thyroid among the conditions Dr. Cotto treats.

CMS data shows 4,554 Medicare services from Dr. Cotto across 25 procedure codes in 2024, for 309 Medicare patients. Medicare paid $118,508 for them. Every service was in an office.

CMS counts 309 Medicare patients who saw Dr. Cotto in 2024. The largest group is 65 to 74, with 159 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cotto's median patient age at 55, with 78% women.

In 2024, Dr. Cotto wrote 5,558 Medicare Part D claims for 737 patients. 35% of them were for generic drugs. CMS names the drug for 5,136 of them, across 66 drugs with 11 or more claims each, at $2,755,579 in total drug cost. In 2023, CMS named 4,475 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cotto for performance year 2024, reported as part of a group. Dr. Cotto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cotto as offering telehealth.

Dmand AI links 1 paper to Dr. Cotto in 2021. Dr. Cotto's most frequent co-authors are Maria E. Gutierrez, MD, Maxwell Ethan Horowitz, DO and Geetanjali Kale, MBBS.

CMS Open Payments shows 911 general payments to Dr. Cotto from 61 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $1,960.

Dr. Cotto graduated from San Juan Bautista School of Medicine in 2009.

Dr. Cotto is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.